GlassScriptPhysician profile
Alexander L Wallner
NPI 1912439142
$1,436.98
in general payments reported to CMS, 2019-2025
11 companies · $833 in 2025
The $833 reported for 2025 was more than what 94% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $47.66 · 2022: $137 · 2023: $17.09 · 2024: $403 · 2025: $833.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,252.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $424.89 | 2022-2025 | Cardiomems, Mitraclip |
| Boston Scientific Corporation | $311.12 | 2025 | General - Therapies, Avvigo Guidance System, Bodyguardian |
| Abiomed | $142.08 | 2025 | |
| Zoll Circulation INC | $141.51 | 2024 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Cardiva Medical, INC. | $114.13 | 2024 | Savvywire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.34 | 2021-2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $67.59 | 2025 | |
| Pfizer INC. | $52.74 | 2025 | |
| Novo Nordisk INC | $40.67 | 2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.71 | 2025 | Jardiance |
| Amgen INC. | $14.20 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Wallner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.